Clinical Trial Update: Sodium Nitrite in Lung Transplant Patients to Minimize the Risk of Pulmonary Graft Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 trial of sodium nitrite in lung transplant patients to reduce pulmonary graft dysfunction was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft Dysfunction
• Lung Transplant Complications

Drugs mentioned

• sodium nitrite (sodium nitrite)

Snippet

Sponsor: Gladwin, Mark, MD | Conditions: Primary Graft Dysfunction | Phase 2 | Status: TERMINATED | Results posted: 2018-08-01